AFP464
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AFP464, covering 2012-01-09 to 2014-02-24. Get the full timeline:
Most recent: Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]